SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    NIH. National Institutes of Health Consensus Conference: surgery for epilepsy. JAMA 1999;264:72933.
  • 2
    Borst P, Evers R, Kool M, et al. A family of drug transporters: the multidrug-resistance associated proteins. J Natl Cancer Inst 2000;92:1295302.
  • 3
    Schinkel AH. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 1999;36:17994.
  • 4
    Cordon-Cardo C, O'Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 1989;86:6958.
  • 5
    Thiebaut F, Tsuruo T, Hamada H, et al. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein. J Histochem Cytochem 1989;37:15964.
  • 6
    Tatsuta T, Naito M, Oh T, et al. Functional involvement of P-glycoprotein in blood–brain barrier. J Biol Chem 1992;267:2038391.
  • 7
    Golden PL & Pardridge WM. Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain. Cell Mol Neurobiol 2000;20:16581.
  • 8
    Sisodiya SM, Heffernan J, Squier MV. Over-expression of P-glycoprotein in malformations of cortical development. Neuroreport 1999;10:343741.
  • 9
    Sisodiya SM, Lin WR, Squier MV, et al. Multidrug-resistance protein 1 in focal cortical dysplasia. Lancet 2001;357:423.
  • 10
    Lazarowski A, Sevlever G, Taratuto A, et al. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy. Pediatr Neurol 1999;21:7314.
  • 11
    Tishler DM, Weinberg KI, Hinton DR, et al. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995;36:16.
  • 12
    Kelland LR. Preclinical perspectives on platinum resistance. Drugs 2000;59(suppl 4):18.
  • 13
    Desai S, Goodrich K, Mayberg MR, et al. Mechanisms of endothelial survival under shear stress. In: KobilerD, LustigS, ShapiraS, eds. Blood-brain barrier delivery and brain pathology. Norwell MA: Kluwer, 2001
  • 14
    Im MJ, Riek RP, Graham RM. A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor, II: purification, characterization, and reconstitution. J Biol Chem 1990;265:1895260.
  • 15
    Liu B, Sun D, Xia W, et al. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1). J Natl Cancer Inst 1997;89:15249.
  • 16
    Seetharaman S, Barrand MA, Maskell L, et al. Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. J Neurochem 1998;70:11519.
  • 17
    Cornford EM, Gee MN, Swartz BE, et al. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx. Ann Neurol 1998;43:8018.
  • 18
    Cornford EM, Hyman S, Cornford ME, et al. Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier. J Cereb Blood Flow Metab 1998;18:2642.
  • 19
    Janigro D. Blood-brain barrier ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res 1999;37:22332.
  • 20
    Sisodiya SM, Lin WR, Squier MV, et al. Multidrug-resistance protein 1 in focal cortical dysplasia. Lancet 2001;357:423.
  • 21
    Tishler DM, Weinberg KI, Hinton DR, et al. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 1995;36:16.
  • 22
    Jetté L, Tetu B, B'Eliveau R. High levels of P-glycoprotein detected in isolated brain capillaries. Biochim Biophys Acta 1993;1150:14754.
  • 23
    Jetté L, Murphy GF, Leclerc JM, et al. Interaction of drugs with P-glycoprotein in brain capillaries. Biochem Pharmacol 1995;50:17019.
  • 24
    Regina A, Koman A, Piciotti M, et al. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 1998;71:70515.
  • 25
    Iwahana M, Utoguchi N, Mayumi T, et al. Drug resistance and P-glycoprotein expression in endothelial cells of newly formed capillaries induced by tumors. Anticancer Res 1998;18:297780.
  • 26
    Koman RA, Piciotti M, El Hafny B, et al. MRPl multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 1998;71:70515.
  • 27
    Matsuoka Y, Okazaki M, Kitamura Y, et al. Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol 1999;39:38392.DOI: 10.1002/(sici)1097-4695(19990605)39:3<383::aid-neu5>3.3.co;2-w
  • 28
    Gattis WA & May DB. Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review. Ann Pharmacother 1996;30:5206.
  • 29
    Neef C & Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 1988;43:3725.
  • 30
    Smith AJ, De Vree JM, Ottenhoff R, et al. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice. Hepatology 1998;28:5306.